{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:29:12Z","timestamp":1780684152194,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["133626"],"award-info":[{"award-number":["133626"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.trim.2017.12.001","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T03:47:45Z","timestamp":1512532065000},"page":"29-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Pre-transplant AT 1 R antibodies correlate with early allograft rejection"],"prefix":"10.1016","volume":"46","author":[{"given":"Alison J.","family":"Gareau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Wiebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Pochinco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian W.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Nickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.trim.2017.12.001_bb0005","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"14","key":"10.1016\/j.trim.2017.12.001_bb0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.trim.2017.12.001_bb0015","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ajt.12160","article-title":"Antibodies beyond HLA","volume":"13","author":"Nickerson","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.trim.2017.12.001_bb0020","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.trim.2017.12.001_bb0025","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/tri.12371","article-title":"The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes","volume":"27","author":"Banasik","year":"2014","journal-title":"Transpl. Int."},{"issue":"9","key":"10.1016\/j.trim.2017.12.001_bb0030","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/TP.0b013e3182692ad2","article-title":"Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation","volume":"94","author":"Hiemann","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.12.001_bb0035","article-title":"Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome","author":"Reinsmoen","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.12.001_bb0040","article-title":"The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation","author":"Lee","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"issue":"8","key":"10.1016\/j.trim.2017.12.001_bb0045","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.transproceed.2014.09.029","article-title":"Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss","volume":"46","author":"Banasik","year":"2014","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/j.trim.2017.12.001_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trim.2013.10.007","article-title":"The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes","volume":"30","author":"Banasik","year":"2014","journal-title":"Transpl. Immunol."},{"issue":"10","key":"10.1016\/j.trim.2017.12.001_bb0055","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2017.12.001_bb0060","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/ajt.12168","article-title":"Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury","volume":"13","author":"Cardinal","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2017.12.001_bb0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-6143.2005.00690.x","article-title":"Antibody response against the glomerular basement membrane protein Agrin in patients with transplant glomerulopathy","volume":"5","author":"Joosten","year":"2005","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.trim.2017.12.001_bb0070","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/ajt.12592","article-title":"Immune responses to collagen-IV and fibronectin in renal transplant recipients with transplant glomerulopathy","volume":"14","author":"Angaswamy","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2017.12.001_bb0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00007890-197708000-00003","article-title":"Studies on the strength of HLA antigens in related donor kidney transplants","volume":"24","author":"Opelz","year":"1977","journal-title":"Transplantation"},{"issue":"9470","key":"10.1016\/j.trim.2017.12.001_bb0080","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(05)66458-6","article-title":"Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies","volume":"365","author":"Opelz","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.trim.2017.12.001_bb0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ndt\/gfp526","article-title":"Antibody-mediated rejection following transplantation from an HLA-identical sibling","volume":"25","author":"Grafft","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"issue":"12","key":"10.1016\/j.trim.2017.12.001_bb0090","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0b013e3181fd97f1","article-title":"Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients","volume":"90","author":"Reinsmoen","year":"2010","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.trim.2017.12.001_bb0095","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0002-9440(10)62557-6","article-title":"Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat","volume":"160","author":"Joosten","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.trim.2017.12.001_bb0100","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.trim.2017.12.001_bb0105","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.transproceed.2014.11.055","article-title":"Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation","volume":"47","author":"Lee","year":"2015","journal-title":"Transplant. Proc."},{"issue":"10","key":"10.1016\/j.trim.2017.12.001_bb0110","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1111\/ajt.12396","article-title":"Type 1 receptor antibodies: great expectations?","volume":"13","author":"Tinckam","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.12.001_bb0115","doi-asserted-by":"crossref","DOI":"10.1111\/nep.12441","article-title":"C4d negative antibody mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor specific antibodies","author":"Fuss","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"10.1016\/j.trim.2017.12.001_bb0120","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar4503","article-title":"Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients","volume":"16","author":"G\u00fcnther","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.trim.2017.12.001_bb0125","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.trim.2017.12.001_bb0130","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.humimm.2013.06.034","article-title":"Role of angiotensin II type 1 receptor-activating antibodies in solid organ transplantation","volume":"74","author":"Reinsmoen","year":"2013","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.trim.2017.12.001_bb0135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jlb.56.5.559","article-title":"Essential involvement of interleukin-8 (IL-8) in acute inflammation","volume":"56","author":"Harada","year":"1994","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.trim.2017.12.001_bb0140","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.188.9.1757","article-title":"Endothelial cell \u201cmemory\u201d of inflammatory stimulation: human venular endothelial cells store interleukin 8 in Weibel-Palade bodies","volume":"188","author":"Wolff","year":"1998","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.trim.2017.12.001_bb0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1189\/jlb.1204712","article-title":"Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes","volume":"78","author":"Schutyser","year":"2005","journal-title":"J. Leukoc. Biol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327417301077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327417301077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T12:55:53Z","timestamp":1535201753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327417301077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":29,"alternative-id":["S0966327417301077"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2017.12.001","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-transplant AT1R antibodies correlate with early allograft rejection","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2017.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}